Letters

Few university students from overseas have been vaccinated against meningococcal infection

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7278.102 (Published 13 January 2001) Cite this as: BMJ 2001;322:102
  1. Matthew R Edmunds, 4th year medical student,
  2. James E Davison, 4th year medical student,
  3. Annette L Wood ([email protected]), consultant in communicable disease control,
  4. Vijay Raichura, medical officer
  1. University of Birmingham, Birmingham B15 2TT
  2. Birmingham Health Authority, Birmingham B16 9RG
  3. University of Birmingham, Health Centre, Birmingham B15 2SE

    EDITOR—It is now a year since the new conjugated meningococcal group C vaccine was introduced to the United Kingdom.1 Students in higher education are at a higher risk of meningococcal disease than other students and were targeted in the government vaccination campaign. Because of the limited supply and late licensing of the new vaccine the pre-existing polysaccharide vaccine was used.

    To determine the effect of the policy we performed a cross sectional study of 3028 first year undergraduate and overseas postgraduate students …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe